1. Jones AP, Kermode AG, Lucas RM, Carroll WM, Nolan D, Hart P. Circulating immune cells in multiple sclerosis. Clinical & Experimental Immunology. 2017;187(2):193-203. [ DOI:10.1111/cei.12878] [ PMID] [ ] 2. Iranmanesh S, Tirgari B, Tofighi M, Forouzi MA. Spiritual wellbeing and perceived uncertainty in patients with multiple sclerosis in south-east Iran. International Journal of Palliative Nursing. 2014;20(10):483-92. [ DOI:10.12968/ijpn.2014.20.10.483] [ PMID] 3. Taraghi Z, Ilali E, Abedini M, Zarvani A, Khoshnama I, Mohammadpour R, et al. Quality of life among multiple sclerosis patients. Iran Journal of Nursing. 2007;20(50):51-9. 4. Currie R. Spasticity: a common symptom of multiple sclerosis. Nursing Standard (through 2013). 2001;15(33):47. [ DOI:10.7748/ns2001.05.15.33.47.c3021] [ PMID] 5. Shiri V, Emami M, Shiri E. Investigating the relationship between selective attention and cognitive flexibility with balance in patients with relapsing-remitting multiple sclerosis. Archives of Rehabilitation. 2018;18(4):296-305. [ DOI:10.21859/jrehab.18.4.4] 6. O'Connor P, Comi G, Freedman M, Miller A, Kappos L, Bouchard J, et al. the MRI-AC in Houston, Texas. Long-term safety and efficacy of teriflunomide: nine-year follow-up of the randomized TEMSO study. Neurology. 2016;86(10):920-30. [ DOI:10.1212/WNL.0000000000002441] [ PMID] [ ] 7. Bomprezzi R. Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview. Therapeutic advances in neurological disorders. 2015;8(1):20-30. [ DOI:10.1177/1756285614564152] [ PMID] [ ] 8. Rosenkranz T, Novas M, Terborg C. PML in a patient with lymphocytopenia treated with dimethyl fumarate. New England journal of medicine. 2015;372(15):1476-8. [ DOI:10.1056/NEJMc1415408] [ PMID] 9. Nicholas J, Boster A, Wu N, Yeh W-S, Fay M, Kendter J, et al. Comparison of disease-modifying therapies for the management of multiple sclerosis: analysis of healthcare resource utilization and relapse rates from US insurance claims data. PharmacoEconomics-open. 2018;2(1):31-41. [ DOI:10.1007/s41669-017-0035-2] [ PMID] [ ] 10. Phillips JT, Hutchinson M, Fox R, Gold R, Havrdova E. Managing flushing and gastrointestinal events associated with delayed-release dimethyl fumarate: experiences of an international panel. Multiple sclerosis and related disorders. 2014;3(4):513-9. [ DOI:10.1016/j.msard.2014.03.003] [ PMID] 11. Arvin AM, Wolinsky JS, Kappos L, Morris MI, Reder AT, Tornatore C, et al. Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management. JAMA neurology. 2015;72(1):31-9. [ DOI:10.1001/jamaneurol.2014.3065] [ PMID] [ ] 12. Solaro C, Gamberini G, Masuccio FG. Depression in multiple sclerosis: epidemiology, aetiology, diagnosis and treatment. CNS drugs. 2018;32(2):117-33. [ DOI:10.1007/s40263-018-0489-5] [ PMID] 13. Soelberg Sorensen P. Safety concerns and risk management of multiple sclerosis therapies. Acta Neurologica Scandinavica. 2017;136(3):168-86. [ DOI:10.1111/ane.12712] [ PMID] 14. Shear N. Litt's Drug Eruption & Reaction Manual: CRC Press; 2017. [ DOI:10.1201/b20727] 15. Abdar M, Ebrahimifar P, Etemadifar M. The outbreak fingolimod cardiovascular side effects in relapsing-remitting multiple sclerosis patient: A longitudinal study in an Iranian population. ARYA atherosclerosis. 2016;12(6):274. 16. Camm J, Hla T, Bakshi R, Brinkmann V. Cardiac and vascular effects of fingolimod: mechanistic basis and clinical implications. American heart journal. 2014;168(5):632-44. [ DOI:10.1016/j.ahj.2014.06.028] [ PMID] 17. Zhang Z, Zeng C, Peng B. Adsorption properties of magnetic carbon nanotubes for patulin removal from aqueous solution systems. Food Control. 2019;102:1-10. [ DOI:10.1016/j.foodcont.2019.02.038] 18. Turaka K, Bryan JS. Does fingolimod in multiple sclerosis patients cause macular edema? Journal of neurology. 2012;259(2):386-8. [ DOI:10.1007/s00415-011-6367-4] [ PMID] 19. Akiyama H, Suzuki Y, Hara D, Shinohara K, Ogura H, Akamatsu M, et al. Improvement of macular edema without discontinuation of fingolimod in a patient with multiple sclerosis: A case report. Medicine. 2016;95(29). [ DOI:10.1097/MD.0000000000004180] [ PMID] [ ] |
